Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : Nilotinib
CAS No.: 641571-10-0
Catalog No.: PC-42407Not For Human Use, Lab Use Only.
Nilotinib (AMN-107) is a potent, selective, orally available inhibitor of both native and mutant Bcr-Abl with IC50 of 20-80 nM.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 100 mg | $158 | In stock | |
| 500 mg | $288 | In stock | |
| 1 g | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Nilotinib (AMN-107) is a potent, selective, orally available inhibitor of both native and mutant Bcr-Abl with IC50 of 20-80 nM.
Nilotinib (AMN-107) inhibits proliferation of Ba/F3 cells expressing G250E, E255K(V), F317L, M351T, F486S, M244V, L248R, Q252H, Y253H, E255K, E279K, E282D, V289S, and L348M Bcr-Abl mutants at <1 uM.
Nilotinib (AMN-107) also inhibits activated forms of PDGFR and c-Kit with IC50 of 30-200 nM.
Nilotinib (AMN-107) prolongs survival of mice with leukemia due to imatinib-resistant mutants of Bcr-Abl.
| M.Wt | 529.5158 | |
| Formula | C28H22F3N7O | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
DMSO: 28 mg/mL |
|
| Chemical Name/SMILES |
Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]- |
|
1. Weisberg E, et al. Cancer Cell. 2005 Feb;7(2):129-41.
2. O'Hare T, et al. Cancer Res. 2005 Jun 1;65(11):4500-5.
3. Golemovic M, et al. Clin Cancer Res. 2005 Jul 1;11(13):4941-7.
4. Stover EH, et al. Blood. 2005 Nov 1;106(9):3206-13.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
